Evidence map›Paper›PMID 29172941›Full record

ArticleHuman vaccines & immunotherapeutics2018

Reporting of adverse events following immunizations in Ghana - Using disproportionality analysis reporting ratios.

Daniel N A Ankrah, Delese M Darko, George Sabblah, Aukje Mantel-Teeuwisse, Hubert M G Leufkens

Abstract read
In one paragraph

Article in Human vaccines & immunotherapeutics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. A Qualitative Study to Assess Challenges Faced During AEFI Surveillance.Indian journal of community medicine : official publication of Indian Association of Preventive & Social Medicine · 2025
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Daniel N A Ankraha Department of Pharmacy , Korle-Bu Teaching Hospital , Korle-Bu, Accra , Ghana.
Delese M Darkoc Food and Drugs Authority , Cantonments-Accra , Ghana.
George Sabblahc Food and Drugs Authority , Cantonments-Accra , Ghana.
Aukje Mantel-Teeuwisseb Division of Pharmacoepidemiology & Clinical Pharmacology , Utrecht Institute for Pharmaceutical Sciences (UIPS) , Utrecht , the Netherlands.
Hubert M G Leufkensb Division of Pharmacoepidemiology & Clinical Pharmacology , Utrecht Institute for Pharmaceutical Sciences (UIPS) , Utrecht , the Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTimely reporting of safety information post vaccination is pivotal for the success of any vaccination program. Reports of adverse events following immunization (AEFI) of 6 different vaccinations from Ghana were analysed for signals.

methodsDe-identified data from active surveillance for AEFIs after 2009 AH1N1 influenza, yellow fever, meningitis, measles-rubella, pneumococcal-rotavirus and human papilloma virus vaccinations were used. All vaccinations occurred between January 2010 and December 2013. The ten most occurring events for each vaccination were captured and arranged using Medical Dictionary for Regulatory Authorities (MedDRA) Preferred Term (PT) and System Organ Classification (SOC) codes. Adverse event incidence rates were calculated for each vaccine type, and signals were generated using proportional reporting ratios (PRR).

resultsA total number of 5,141 reports were analysed ranging from 33 (human papilloma virus) to 1958 (measles-rubella). Between 22% and 55% of all AEFIs per vaccine type were collected on the day of vaccination. For each vaccine type, at least 87% of all reported AEFIs occurred in the first 7 days post-vaccination. Multiple reports were received per vaccine type. For the MR vaccine, urticarial recorded the highest attack rate of 6.6 (95% CI 6.2, 7.1) per 100,000 vaccines. The AEFI with the highest PRR for both human papilloma and measles-rubella vaccines was abdominal pain, recording a PRR of 8.15 (95% CI 3.46, 19.23) and 43.75 (95% CI 17.81, 107.45) respectively.

conclusionThese results underscore the competency of public health systems in sub-Saharan African countries (like Ghana) to identify most frequently occurring and important vaccine related safety issues.

Indexed as

Abdominal PainAdverse Drug Reaction Reporting SystemsFemaleGhanaHumansImmunization ProgramsIncidenceInfantInfant, NewbornMaleUrticariaVaccinationactive surveillanceGhanaimmunizationproportional reporting ratiosafety

Identifiers

PMID29172941
PMCPMC5791568

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.